# DBS for Depression

> **NCT06096207** · PHASE1 · RECRUITING · sponsor: **Northwell Health** · enrollment: 20 (estimated)

## Conditions studied

- Treatment Resistant Depression

## Interventions

- **DEVICE:** Medtronic SenSight Directional DBS lead

## Key facts

- **NCT ID:** NCT06096207
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-18
- **Primary completion:** 2030-10-18
- **Final completion:** 2038-10-18
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06096207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06096207, "DBS for Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06096207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*